It was front page news around the world: a drug designed to disrupt malignant melanoma, the deadliest form of skin cancer, was so successful in its latest round of testing in humans that the tests were halted – like ...
Analytical Chemistry
Jul 19, 2011
0
0
The journal Accounts of Chemical Research has published the article "Anion Transporters and Biological Systems", by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty ...
Biochemistry
Apr 19, 2013
0
0
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
Bio & Medicine
Jun 13, 2011
1
1
Since the completion of the Human Genome Project, which identified nearly 20,000 protein-coding genes, scientists have been trying to decipher the roles of those genes. A new approach developed at MIT, the Broad Institute, ...
Biotechnology
Dec 12, 2013
0
0
Red coloration—historically seen as costly in vertebrates—historically seen as costly in vertebrates—might represent some physiological benefit after all, according to research published in the journal Physiological ...
Plants & Animals
Jan 28, 2013
6
0
Suspicion of melanoma: In the future, doctors can pull out a new type of microscope to get to the bottom of suspicious changes in the skin. It provides a high-resolution image of skin areas of any size – and so quickly ...
Engineering
May 10, 2011
0
0
(Phys.org)—Malignant melanoma is the most aggressive type of skin cancer. In more than 50 percent of affected patients a particular mutation plays an important role. As the life span of the patients carrying the mutation ...
Bio & Medicine
Feb 15, 2013
0
0
Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only when patients also receive large doses of drugs designed to help immune cells multiply ...
Bio & Medicine
Sep 17, 2010
0
0
Studies conducted in yeast show that exposure to ultraviolet light (UV) induces new types of DNA damage that may cause the deadliest form of skin cancer, malignant melanoma.
Molecular & Computational biology
Nov 17, 2020
0
40
Using a gene-editing system originally developed to delete specific genes, MIT researchers have now shown that they can reliably turn on any gene of their choosing in living cells.
Biotechnology
Dec 10, 2014
1
0
